Howland Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.46M Sell
29,636
-26
-0.1% -$5.59K 0.27% 66
2026
Q1
$6.45M Sell
29,662
-694
-2% -$154K 0.26% 64
2025
Q4
$6.94M Buy
30,356
+1,579
+5% +$360K 0.26% 63
2025
Q3
$6.66M Buy
28,777
+286
+1% +$58.2K 0.25% 65
2025
Q2
$5.29M Sell
28,491
-12
-0% -$2.23K 0.22% 69
2025
Q1
$5.97M Buy
28,503
+4,924
+21% +$957K 0.27% 61
2024
Q4
$4.19M Buy
23,579
+95
+0.4% +$17.5K 0.18% 77
2024
Q3
$4.64M Sell
23,484
-275
-1% -$51.3K 0.2% 71
2024
Q2
$4.08M Sell
23,759
-1,222
-5% -$202K 0.19% 74
2024
Q1
$4.55M Sell
24,981
-1,005
-4% -$173K 0.22% 74
2023
Q4
$4.03M Sell
25,986
-176
-0.7% -$25.7K 0.21% 74
2023
Q3
$3.9M Sell
26,162
-675
-3% -$99.1K 0.23% 71
2023
Q2
$3.62M Sell
26,837
-52
-0.2% -$7.63K 0.21% 73
2023
Q1
$4.29M Buy
26,889
+761
+3% +$116K 0.26% 67
2022
Q4
$4.22M Buy
26,128
+1,575
+6% +$241K 0.26% 68
2022
Q3
$3.29M Buy
24,553
+2,205
+10% +$316K 0.21% 74
2022
Q2
$3.42M Buy
22,348
+4,635
+26% +$708K 0.21% 70
2022
Q1
$2.87M Buy
17,713
+313
+2% +$45.5K 0.15% 75
2021
Q4
$2.36M Buy
17,400
+50
+0.3% +$5.91K 0.12% 84
2021
Q3
$1.87M Sell
17,350
-155
-0.9% -$17.7K 0.1% 92
2021
Q2
$1.97M Buy
17,505
+114
+0.7% +$12.8K 0.1% 91
2021
Q1
$1.88M Sell
17,391
-220
-1% -$23.5K 0.1% 91
2020
Q4
$1.89M Sell
17,611
-122
-0.7% -$11.7K 0.11% 90
2020
Q3
$1.55M Sell
17,733
-135
-0.8% -$12.7K 0.1% 90
2020
Q2
$1.75M Sell
17,868
-797
-4% -$70.2K 0.13% 87
2020
Q1
$1.42M Buy
18,665
+3,846
+26% +$328K 0.12% 88
2019
Q4
$1.31M Buy
14,819
+379
+3% +$31.5K 0.09% 102
2019
Q3
$1.09M Sell
14,440
-1,110
-7% -$76.1K 0.08% 109
2019
Q2
$1.13M Buy
15,550
+1,350
+10% +$106K 0.09% 106
2019
Q1
$1.14M Sell
14,200
-1,358
-9% -$111K 0.09% 104
2018
Q4
$1.43M Sell
15,558
-10,866
-41% -$956K 0.13% 89
2018
Q3
$2.5M Sell
26,424
-6,606
-20% -$626K 0.19% 85
2018
Q2
$3.06M Sell
33,030
-4,694
-12% -$458K 0.24% 79
2018
Q1
$3.57M Sell
37,724
-122
-0.3% -$13.4K 0.29% 75
2017
Q4
$3.66M Sell
37,846
-241
-0.6% -$22.7K 0.29% 72
2017
Q3
$3.38M Sell
38,087
-2,720
-7% -$207K 0.28% 72
2017
Q2
$2.96M Sell
40,807
-875
-2% -$58.8K 0.25% 74
2017
Q1
$2.72M Buy
41,682
+113
+0.3% +$7.1K 0.24% 78
2016
Q4
$2.6M Sell
41,569
-345
-0.8% -$21.1K 0.24% 76
2016
Q3
$2.64M Buy
41,914
+950
+2% +$61.5K 0.25% 75
2016
Q2
$2.54M Sell
40,964
-272
-0.7% -$16.6K 0.24% 75
2016
Q1
$2.35M Sell
41,236
-819
-2% -$45.6K 0.24% 75
2015
Q4
$2.49M Sell
42,055
-155
-0.4% -$8.93K 0.25% 78
2015
Q3
$2.3M Sell
42,210
-408
-1% -$26.6K 0.25% 75
2015
Q2
$2.86M Sell
42,618
-50
-0.1% -$3.26K 0.29% 71
2015
Q1
$2.5M Sell
42,668
-30
-0.1% -$1.81K 0.25% 77
2014
Q4
$2.79M Sell
42,698
-580
-1% -$36.6K 0.28% 73
2014
Q3
$2.5M Sell
43,278
-2,949
-6% -$164K 0.26% 76
2014
Q2
$2.61M Buy
46,227
+4,220
+10% +$221K 0.27% 75
2014
Q1
$2.16M Buy
42,007
+2,975
+8% +$150K 0.24% 81
2013
Q4
$2.06M Buy
39,032
+1,173
+3% +$57.7K 0.26% 78
2013
Q3
$1.69M Sell
37,859
-170
-0.4% -$7.54K 0.23% 83
2013
Q2
$1.57M Buy
+38,029
New +$1.66M 0.25% 77

Other funds holding ABBV

Howland Capital Management's ABBV Position: Q2 2026 in Review

Howland Capital Management reduced its AbbVie (ABBV) stake by 0.09% in Q2 2026, selling an estimated $5.59K and leaving 29,636 shares worth $7.46M. The position accounts for 0.27% of the portfolio, ranked #66.

Howland Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Howland Capital Management held 29,636 shares of AbbVie worth $7.46M as of Q2 2026.
  • Howland Capital Management sold 26 AbbVie shares in Q2 2026, an estimated $5.59K.
  • AbbVie made up 0.27% of Howland Capital Management's portfolio in Q2 2026, its #66 holding.
  • Howland Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.